We report on a case of repeated MDPV consumptions that resulted in severe psychosis and agitation prompting the concomitant abuse of benzodiazepines. A 27-year-old man was found irresponsive in his apartment and was brought to the emergency department (ED) of a local hospital. When in ED, he rapidly recovered and self-reported to have recently injected some doses of MDPV that he had bought in the Internet. He left the hospital withoutmedical cares. 15 days after, he was again admitted to the same ED due to severe agitation, delirium and hallucinations, and reported the use of MDPV and pharmaceutical drugs during the preceding week. He was sedated with diazepam and chlorpromazine. Urine samples collected in both occasions were sent for testing using liquid chromatography–high resolution mass spectrometry (LC–HRMS) and liquid chromatography–high resolution multiple mass spectrometry (LC–HRMS/MS) on an Orbitrap. The LC–HRMS analysis revealed the presence of MDPV and its phase I and phase II metabolites (demethylenyl-MDPV, demethylenyl-methyl-MDPV, demethylenylmethyl- oxo-MDPV, demethylenyl-hydroxy-alkyl-MDPV, demethylenyl-methyl-hydroxy alkyl-MDPV, demethylenyl-oxo-MDPV and their corresponding glucuronides), alprazolam and alprazolam metabolite at the first ED admission; at the time of the second ED access, the same MDPV metabolites, alprazolam, temazepam, and chlordiazepoxide were detected together with diazepam and metabolites. LC–HRMS/MS was use to determine the following concentrations, respectively on his first and second admission:MDPV 55 ng/mL, alprazolam 114 ng/mL, a-hydroxyalprazolam 104 ng/mL; MDPV 35 ng/mL, alprazolam 10.4 ng/mL, a -hydroxyalprazolam 13 ng/mL; chlordiazepoxide 13 ng/mL, temazepam 170 ng/mL, diazepam 1.3 ng/mL, nordiazepam 61.5, oxazepam 115 ng/mL. The toxicological findings corroborated the referred concomitant use of multiple pharmaceutical drugs and benzodiazepines. Confirmation of previous hypothesis on human metabolism of MDPV could be inferred by the analysis of urine.

A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: Determination of MDPV metabolites by LC-HRMS and discussion of the case / E. Bertol; F. Mari; R. Boscolo Berto; G. Mannaioni; F. Vaiano; D. Favretto. - In: FORENSIC SCIENCE INTERNATIONAL. - ISSN 0379-0738. - ELETTRONICO. - 243:(2014), pp. 149-155. [10.1016/j.forsciint.2014.08.002]

A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: Determination of MDPV metabolites by LC-HRMS and discussion of the case

BERTOL, ELISABETTA;MARI, FRANCESCO;MANNAIONI, GUIDO;VAIANO, FABIO;
2014

Abstract

We report on a case of repeated MDPV consumptions that resulted in severe psychosis and agitation prompting the concomitant abuse of benzodiazepines. A 27-year-old man was found irresponsive in his apartment and was brought to the emergency department (ED) of a local hospital. When in ED, he rapidly recovered and self-reported to have recently injected some doses of MDPV that he had bought in the Internet. He left the hospital withoutmedical cares. 15 days after, he was again admitted to the same ED due to severe agitation, delirium and hallucinations, and reported the use of MDPV and pharmaceutical drugs during the preceding week. He was sedated with diazepam and chlorpromazine. Urine samples collected in both occasions were sent for testing using liquid chromatography–high resolution mass spectrometry (LC–HRMS) and liquid chromatography–high resolution multiple mass spectrometry (LC–HRMS/MS) on an Orbitrap. The LC–HRMS analysis revealed the presence of MDPV and its phase I and phase II metabolites (demethylenyl-MDPV, demethylenyl-methyl-MDPV, demethylenylmethyl- oxo-MDPV, demethylenyl-hydroxy-alkyl-MDPV, demethylenyl-methyl-hydroxy alkyl-MDPV, demethylenyl-oxo-MDPV and their corresponding glucuronides), alprazolam and alprazolam metabolite at the first ED admission; at the time of the second ED access, the same MDPV metabolites, alprazolam, temazepam, and chlordiazepoxide were detected together with diazepam and metabolites. LC–HRMS/MS was use to determine the following concentrations, respectively on his first and second admission:MDPV 55 ng/mL, alprazolam 114 ng/mL, a-hydroxyalprazolam 104 ng/mL; MDPV 35 ng/mL, alprazolam 10.4 ng/mL, a -hydroxyalprazolam 13 ng/mL; chlordiazepoxide 13 ng/mL, temazepam 170 ng/mL, diazepam 1.3 ng/mL, nordiazepam 61.5, oxazepam 115 ng/mL. The toxicological findings corroborated the referred concomitant use of multiple pharmaceutical drugs and benzodiazepines. Confirmation of previous hypothesis on human metabolism of MDPV could be inferred by the analysis of urine.
2014
243
149
155
E. Bertol; F. Mari; R. Boscolo Berto; G. Mannaioni; F. Vaiano; D. Favretto
File in questo prodotto:
File Dimensione Formato  
2014 A mixed MDPV and benzodiazepine intoxication in a chronic drug.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 265.74 kB
Formato Adobe PDF
265.74 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/894727
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 25
social impact